1-5 of 5
Laura Dessanti
Close
Sort by
Journal Articles

FCR (Fludarabine, Cyclophosphamide, Rituximab) Followed By 90 yttrium Ibritumomab Tiuxetan for the Treatment of Relapsed Grades 1 and 2 Follicular Lymphoma. Long Term Efficacy and Safety Results of 9 Cases

Francesco Pisani, Member, ID:, 1012314, Maria Laura Dessanti, MD, Diana Giannarelli, MS, Ramy Kayal, MD, Francesco Marchesi, MD, Rosa Sciuto, MD, Sandra Rea, MD, Carlo Ludovico Maini, MD, Mirella Marino, MD
Journal: Blood
Blood (2014) 124 (21): 5452.
https://doi.org/10.1182/blood.V124.21.5452.5452
Published: 2014
Journal Articles

The Poor Outcome of Multiple Myeloma (MM) Patients Carrying At Diagnosis Deleted TP53 and or Amplified MDM4 Might Be Related to the Deregulation of Genes Involved in Cell Cycle Control and DNA Damage Repair

Carolina Terragna, PhD, Marina Martello, Nicoletta Testoni, Emanuele Angelucci, Annamaria Brioli, Stelvio Ballanti, Laura Dessanti, Valerio De Stefano, Gioacchino Catania, Jacopo Peccatori, Luca Castagna, Salvatore Palmieri, Giulia Perrone, Vincenzo Callea, Catello Califano, Anna Baraldi, Enrica Borsi, Luciana Pasini, Mariella Grasso, Pellegrino Musto, Patrizia Tosi, Giovanni Martinelli, Michele Cavo, MD
Journal: Blood
Blood (2012) 120 (21): 1810.
https://doi.org/10.1182/blood.V120.21.1810.1810
Published: 2012
Journal Articles

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Michele Cavo, Lucia Pantani, Maria Teresa Petrucci, Francesca Patriarca, Elena Zamagni, Daniela Donnarumma, Claudia Crippa, Mario Boccadoro, Giulia Perrone, Antonietta Falcone, Chiara Nozzoli, Renato Zambello, Luciano Masini, Anna Furlan, Annamaria Brioli, Daniele Derudas, Stelvio Ballanti, Maria Laura Dessanti, Valerio De Stefano, Angelo Michele Carella, Magda Marcatti, Andrea Nozza, Felicetto Ferrara, Vincenzo Callea, Catello Califano, Annalisa Pezzi, Anna Baraldi, Mariella Grasso, Pellegrino Musto, Antonio Palumbo
Journal: Blood
Blood (2012) 120 (1): 9–19.
https://doi.org/10.1182/blood-2012-02-408898
Published: 2012
Includes: Supplemental data
Journal Articles

Superior Rate of Complete Response with up-Front Velcade-Thalidomide-Dexamethasone Versus Thalidomide-Dexamethasone in Newly Diagnosed Multiple Myeloma Is Not Affected by Adverse Prognostic Factors, Including High-Risk Cytogenetic Abnormalities.

Michele Cavo, M.D., Nicoletta Testoni, B.S., Carolina Terragna, B.S., Giulia Marzocchi, B.S., Sandra Durante, B.S., Renato Zambello, M.D., Chiara Nozzoli, M.D., Lucia Pantani, M.D., Paola Tacchetti, M.D., Luciano Masini, M.D., Michela Ceccolini, M.D., Paola Agostini, M.D., Elena Zamagni, M.D., Valerio De Stefano, M.D., Patrizia Tosi, M.D., Daniele Derudas, M.D., Laura Dessanti, M.D., Stelvio Ballanti, M.D., Salvatore Palmieri, M.D., Andrea Nozza, M.D., Gioacchino Catania, M.D., Jacopo Peccatori, M.D., Alfonso D’Arco, M.D., Pellegrino Musto, M.D., Mariella Grasso, M.D., Maria Caterina Pallotti, M.D., Silvana Pasini, M.D., Pier Paolo Fattori, M.D., Anna Baraldi, M.D., Delia Cangini, M.D., Filippo Ballerini, M.D., Alessandro Petrucci, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2008) 112 (11): 1662.
https://doi.org/10.1182/blood.V112.11.1662.1662
Published: 2008
Journal Articles

Efficacy and Safety of FCR (Fludarabine, Cyclophosphamide, Rituximab) Followed by Yttrium-90 Ibritumomab Tiuxetan in Relapsed Follicular Lymphoma (FL) Patients

Francesco Pisani, Carlo Ludovico Maini, Rosa Sciuto, Laura Dessanti, Antonio Spadea, Andrea Mengarelli, Mariella D’Andrea, Sandra Rea, Luisa Romano, Maria Concetta Petti
Journal: Blood
Blood (2008) 112 (11): 5003.
https://doi.org/10.1182/blood.V112.11.5003.5003
Published: 2008